Neonatal thrombotic microangiopathy secondary to factor I variant with Hirschsprung disease.

Journal of Nephrology
Adi Nitzan-LuquesOded Volovelsky

Abstract

Neonatal thrombotic microangiopathy (TMA) is a rare and severe disease characterized by a triad of non-immune hemolytic anemia, thrombocytopenia, and organ dysfunction in neonates. We describe herein an early-term infant who underwent hemicolectomy at 4 days of age due to intestinal perforation. Following surgery, the patient had recurrent bouts of vomiting and abdominal distention, together with acute kidney injury, non-immune hemolytic anemia, and severe thrombocytopenia. Low complement levels raised the possibility of complement-mediated neonatal TMA. Finally, genetic tests identified a heterozygous mutation in the complement factor I gene. Anti-C5 monoclonal antibody therapy led to complete cessation of the hematological and renal manifestations, but symptoms of intestinal obstruction recurred. Intestinal biopsy demonstrated aganglionosis, compatible with Hirschsprung disease. This presentation is the first known case of neonatal complement-mediated TMA associated with Hirschsprung disease. Moreover, it highlights the importance of considering a diagnosis of TMA in cases of atypical neonatal infectious presentation.

References

Jun 1, 1987·AJR. American Journal of Roentgenology·B NewmanJ A Kirkpatrick
Jun 18, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Aoife M Waters, Christoph Licht
Jul 3, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Marina NorisGiuseppe Remuzzi
Mar 14, 2012·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Lianne M GeerdinkNicole C A J van de Kar
Apr 11, 2015·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Chantal LoiratUNKNOWN HUS International
Mar 1, 2017·Lancet·Fadi FakhouriChantal Loirat
Jul 18, 2019·Clinical Nephrology. Case Studies·H Stella ShinBradley P Dixon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Related Papers

KI Reports
Lilian Monteiro P PalmaSanjeev Sethi
Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine
Thanigachalam DineshkumarT Balasubramaniyan
[Rinshō ketsueki] The Japanese journal of clinical hematology
N Hirabayashi
Seminars in Thrombosis and Hemostasis
Ilene Ceil Weitz
© 2022 Meta ULC. All rights reserved